Latest News and Press Releases
Want to stay updated on the latest news?
-
LOS ANGELES, Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
LOS ANGELES, Sept. 29, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Novo Nordisk A/S, ("Novo" or the "Company") (NYSE: NVO) investors of a class action on behalf of investors that bought...
-
Novo allegedly overstated GLP-1 growth; stock plunged 21.8% on July 29, 2025 after lowering outlook due to compounded drugs, weak expansion, competition.
-
Novo allegedly overstated GLP-1 growth potential; cut 2025 outlook citing compounded drugs and competition, causing shares to drop 21.8% in a day.
-
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Novo To Contact Him Directly To Discuss Their Options If you purchased or...
-
Novo Nordisk (NVO) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
-
The Novo lawsuit alleges it overstated GLP-1 growth potential; stock allegedly plunged 21.8% after cutting 2025 outlook on slower demand and competition.
-
LOS ANGELES, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
-
Novo Nordisk (NVO) Shareholder Lawsuit Filed - Contact Bernstein Liebhard For More Information
-
NEW YORK, Sept. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between May 7, 2025 and July...